• Home
  • About Biomol
  • Contact
  • Español
Biomol

Blood test identifies resistance to radiotherapy in brain metastases

by biomolad | Jun 30, 2022 | Sin categoría

Via: EfeSalud (https://efesalud.com/un-analisis-de-sangre-identifica-la-resistencia-a-la-radioterapia-en-metastasis-cerebral/)   A blood test; that is enough to identify patients resistant to radiotherapy with brain metastases, according to research led by Spaniards...

Alzheimer’s, 75 genetic risk factors identified

by biomolad | Jun 30, 2022 | Sin categoría

Via: EfeSalud (https://efesalud.com/alzheimer-factores-riesgo-genetico/) An international team of scientists has managed to identify 75 genetic risk factors involved in Alzheimer’s disease. This is a highly relevant finding since 42 of the identified factors had...

Recent Posts

  • Blood test identifies resistance to radiotherapy in brain metastases
  • Alzheimer’s, 75 genetic risk factors identified

Recent Comments

No comments to show.
Sevilla

Plaza del Zurraque, 2, Locales 22 y 23, 41010 Sevilla

Mail

biomol@biomol.es

Teléfono

+34 954 33 50 40

Acceso Clientes

Aviso legal | Política de privacidad

© 2022 Biomol SL

Sitio web diseñado por Habermas y desarrollado por Briosso’s Marketing